Experimental Hematology
Volume 38, Issue 6 , Pages 504-515 , June 2010

SNARE-dependent glutamate release in megakaryocytes

  • Catherine J. Thompson

      Affiliations

    • Department of Biology, University of York, York, United Kingdom
    • ,
  • Tatjana Schilling

      Affiliations

    • Department of Biology, University of York, York, United Kingdom
    • ,
  • Martin R. Howard

      Affiliations

    • Department of Haematology, York Health Services, National Health Service Trust, York, United Kingdom
    • ,
  • Paul G. Genever

      Affiliations

    • Department of Biology, University of York, York, United Kingdom
    • Corresponding Author InformationOffprint requests to: Paul G. Genever, Ph.D., Department of Biology (Area 9), University of York, York YO10 5YW, UK

Received 16 November 2009 ,Revised 12 March 2010 ,Accepted 17 March 2010.

References 

  1. de Sauvage FJ, Carver-Moore K, Luoh SM, et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996;183:651–656
  2. Kaushansky K. Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost. 1995;74:521–525
  3. Gordon MS, Hoffman R. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood. 1992;80:302–307
  4. Wendling F, Han ZC. Positive and negative regulation of megakaryocytopoiesis. Baillieres Clin Haematol. 1997;10:29–45
  5. Zheng C, Yang R, Han Z, Zhou B, Liang L, Lu M. TPO-independent megakaryocytopoiesis. Crit Rev Oncol Hematol. 2008;65:212–222
  6. Collingridge GL, Lester RA. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev. 1989;41:143–210
  7. Headley PM, Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol Sci. 1990;11:205–211
  8. Hinoi E, Takarada T, Ueshima T, Tsuchihashi Y, Yoneda Y. Glutamate signaling in peripheral tissues. Eur J Biochem. 2004;271:1–13
  9. Skerry TM, Genever PG. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci. 2001;22:174–181
  10. Genever PG, Wilkinson DJ, Patton AJ, et al. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood. 1999;93:2876–2883
  11. Hitchcock IS, Skerry TM, Howard MR, Genever PG. NMDA receptor-mediated regulation human megakaryocytopoiesis. Blood. 2003;102:1254–1259
  12. Hoogland G, Bos IW, Kupper F, et al. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Neurochem Int. 2005;47:499–506
  13. Zoia C, Cogliati T, Tagliabue E, et al. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol Aging. 2004;25:149–157
  14. Morrell CN, Sun H, Ikeda M, et al. Glutamate mediates platelet activation through the AMPA receptor. J Exp Med. 2008;205:575–584
  15. Murthy VN, De Camilli P. Cell biology of the presynaptic terminal. Annu Rev Neurosci. 2003;26:701–728
  16. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci. 2004;27:509–547
  17. Sollner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell. 1993;75:409–418
  18. Chen YA, Scheller RH. SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol. 2001;2:98–106
  19. Richmond JE, Broadie KS. The synaptic vesicle cycle: exocytosis and endocytosis in Drosophila and C. elegans. Curr Opin Neurobiol. 2002;12:499–507
  20. Zinsmaier KE, Bronk P. Molecular chaperones and the regulation of neurotransmitter exocytosis. Biochem Pharmacol. 2001;62:1–11
  21. Biederer T, Sudhof TC. Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J Biol Chem. 2000;275:39803–39806
  22. Calakos N, Scheller RH. Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle. J Biol Chem. 1994;269:24534–24537
  23. Gerst JE. SNARE regulators: matchmakers and matchbreakers. Biochim Biophys Acta. 2003;1641:99–110
  24. Mochida S. Protein-protein interactions in neurotransmitter release. Neurosci Res. 2000;36:175–182
  25. Novick P, Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol. 1997;9:496–504
  26. Herzog E, Gilchrist J, Gras C, et al. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience. 2004;123:983–1002
  27. Hisano S, Sawada K, Kawano M, et al. Expression of inorganic phosphate/vesicular glutamate transporters (BNPI/VGLUT1 and DNPI/VGLUT2) in the cerebellum and precerebellar nuclei of the rat. Brain Res Mol Brain Res. 2002;107:23–31
  28. Kaneko T, Fujiyama F. Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci Res. 2002;42:243–250
  29. Drachman JG, Rojnuckarin P, Kaushansky K. Thrombopoietin signal transduction: studies from cell lines and primary cells. Methods. 1999;17:238–249
  30. Linden HM, Kaushansky K. The glycan domain of thrombopoietin enhances its secretion. Biochemistry. 2000;39:3044–3051
  31. Sweeney ST, Broadie K, Keane J, Niemann H, O'Kane CJ. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron. 1995;14:341–351
  32. Genever PG, Skerry TM. Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone. FASEB J. 2001;15:1586–1588
  33. Nicholls DG, Sihra TS, Sanchez-Prieto J. Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem. 1987;49:50–57
  34. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature. 1991;352:70–73
  35. Kapuscinski J, Darzynkiewicz Z, Melamed MR. Luminescence of the solid complexes of acridine orange with RNA. Cytometry. 1982;2:201–211
  36. Link E, Edelmann L, Chou JH, et al. Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem Biophys Res Commun. 1992;189:1017–1023
  37. Robinson LJ, Martin TF. Docking and fusion in neurosecretion. Curr Opin Cell Biol. 1998;10:483–492
  38. Ravichandran V, Chawla A, Roche PA. Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. J Biol Chem. 1996;271:13300–13303
  39. Roy R, Laage R, Langosch D. Synaptobrevin transmembrane domain dimerization-revisited. Biochemistry. 2004;43:4964–4970
  40. Morimoto R, Hayashi M, Yatsushiro S, Otsuka M, Yamamoto A, Moriyama Y. Co-expression of vesicular glutamate transporters (VGLUT1 and VGLUT2) and their association with synaptic-like microvesicles in rat pinealocytes. J Neurochem. 2003;84:382–391
  41. Wojcik SM, Rhee JS, Herzog E, et al. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci U S A. 2004;101:7158–7163
  42. Daniels RW, Collins CA, Gelfand MV, et al. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci. 2004;24:10466–10474
  43. Zoccarato F, Cavallini L, Alexandre A. The pH-sensitive dye acridine orange as a tool to monitor exocytosis/endocytosis in synaptosomes. J Neurochem. 1999;72:625–633
  44. Betz A, Okamoto M, Benseler F, Brose N. Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin. J Biol Chem. 1997;272:2520–2526
  45. Fergestad T, Broadie K. Interaction of stoned and synaptotagmin in synaptic vesicle endocytosis. J Neurosci. 2001;21:1218–1227
  46. Henkel AW, Lubke J, Betz WJ. FM1-43 dye ultrastructural localization in and release from frog motor nerve terminals. Proc Natl Acad Sci U S A. 1996;93:1918–1923
  47. Rheuben MB, Autio DM, Xu YF, Atchison WD. Morphometric characterization of the neuromuscular junction of rodents intoxicated with 2,4-dithiobiuret: evidence that nerve terminal recycling processes contribute to muscle weakness. Toxicol Appl Pharmacol. 2004;196:266–286
  48. Takamori S, Rhee JS, Rosenmund C, Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature. 2000;407:189–194
  49. Isakari Y, Sogo S, Ishida T, et al. Gene expression analysis during platelet-like particle production in phorbol myristate acetate-treated MEG-01 cells. Biol Pharm Bull. 2009;32:354–358
  50. Mahaut-Smith MP, Hussain JF, Mason MJ. Depolarization-evoked Ca2+ release in a non-excitable cell, the rat megakaryocyte. J Physiol. 1999;515(Pt 2):385–390
  51. Mason MJ, Mahaut-Smith MP. Measurement and manipulation of intracellular Ca2+ in single platelets and megakaryocytes. Methods Mol Biol. 2004;273:251–276
  52. Thomas D, Mason MJ, Mahaut-Smith MP. Depolarisation-evoked Ca2+ waves in the non-excitable rat megakaryocyte. J Physiol. 2001;537:371–378
  53. Zamponi GW. Regulation of presynaptic calcium channels by synaptic proteins. J Pharmacol Sci. 2003;92:79–83
  54. Bhangu PS, Genever PG, Spencer GJ, Grewal TS, Skerry TM. Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone. 2001;29:16–23

PII: S0301-472X(10)00102-5

doi: 10.1016/j.exphem.2010.03.011

Experimental Hematology
Volume 38, Issue 6 , Pages 504-515 , June 2010

Article Tools

* Image Usage & Resolution